Cancer immunotherapy: dendritic-cell vaccines on the move. (Q52959842)

9 May 2018

title

Cancer immunotherapy: dendritic-cell vaccines on the move. (English)

1 reference

9 May 2018

1 reference

1 reference

Nina Bhardwaj

1 reference

9 May 2018

author name string

Rachel Lubong Sabado

series ordinal

1 reference

9 May 2018

language of work or name

English

0 references

publication date

11 March 2015

1 reference

9 May 2018

published in

Nature

1 reference

9 May 2018

volume

519

1 reference

9 May 2018

issue

7543

1 reference

9 May 2018

page(s)

300-301

1 reference

9 May 2018

Dendritic cell immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Dendritic-cell-based therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Chemokines and chemokine receptors: positioning cells for host defense and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Chemokines as regulators of T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Macrophage inflammatory protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Immunological targeting of cytomegalovirus for glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE14211

Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25762139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25762139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NATURE14211

1 reference

9 May 2018

Dimensions Publication ID

1003892455

0 references

1 reference

9 May 2018